Clinical Trials Directory

Trials / Completed

CompletedNCT06715059

Tele-rehabilitation in Women With Diastasis Recti Abdominis

Effects of Tele-rehabilitation on Inter-Recti Distance, Postural Balance, Abdominal Endurance and Pelvic Floor Functions

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
50 (actual)
Sponsor
Atlas University · Academic / Other
Sex
Female
Age
18 Years – 50 Years
Healthy volunteers
Not accepted

Summary

The aim of this randomized controlled study is to determine the effect of motor-control based telerehabilitation exercise program on inter-recti distance, abdominal endurance, pelvic floor dysfunction, and body-image perception in women with diastasis recti abdominis. Researchers will compare the effects of motor-control-based telerehabilitation exercise program and conventional exercise programs in women with DRA.

Detailed description

Diastasis of recti abdominis (DRA) is defined as a separation of the two rectus abdominis muscles along the linea alba. Increased volume in the abdominal cavity, hormonal changes during pregnancy, neurodevelopmental differences, or abdominal wall laxity may caused. It is very common during pregnancy and may continue in the postnatal period. The loss of abdominal wall stability and weakened pelvic floor muscles may occur with DRA. The abdominal wall is one of the key point for body posture, trunk and pelvic stability. The core stability exercises, pelvic floor training and trunk muscle trainings are some of the exercise regimes options for management of DRA. However, in our best knowledge, there is no study in the literature that evaluates the effect of motor-control based telerehabilitation exercise program in women with DRA.

Conditions

Interventions

TypeNameDescription
OTHERTele-rehabilitation exercise programA progressive core stability exercise program will be performed based on motor control principles via an online platform.
OTHERHome-based exercise programA core stability exercise program will be performed at home.

Timeline

Start date
2021-11-02
Primary completion
2022-12-20
Completion
2024-11-20
First posted
2024-12-04
Last updated
2024-12-04

Locations

2 sites across 1 country: Turkey (Türkiye)

Source: ClinicalTrials.gov record NCT06715059. Inclusion in this directory is not an endorsement.